Arhiva autor

C. Ailioaie

Latest posts by C. Ailioaie (see all)

Articole semnate de acelasi autor in Revista Romana de Pediatrie:

Therapy of chronic pain in juvenile arthritis by complementary and alternative methods

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LX, Nr. 2, An 2011
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

Therapy of chronic pain in juvenile arthritis by complementary and alternative methods

, and

ABSTRACT

In the recent years, the use of complementary and alternative methods in pediatrics has considerably increased, especially for chronic conditions such as juvenile idiopathic arthritis, in which the pain may be a significant problem. The increased interest in complementary and alternative medicine approaches for pain symptoms in pediatric as well as in adult population has focused attention on questions of safety and efficacy. The pursuit of safe, efficacious and cost-effective interventions for chronic pain in children suffering from juvenile arthritis that may be used in place of, or in concert with conventional medical approaches is a worthy goal that should be undertaken with the highest degree of scientific rigor. We need to think creatively and differently in order to educate the medical profession as well as the general public to change their attitude.

Key words: chronic pain, arthritis, child

Full text | PDF

TERAPIA DURERII CRONICE DIN ARTRITA JUVENILA PRIN MIJLOACE COMPLEMENTARE SI ALTERNATIVE

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LX, Nr. 2, An 2011
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

TERAPIA DURERII CRONICE DIN ARTRITA JUVENILA PRIN MIJLOACE COMPLEMENTARE SI ALTERNATIVE

, and

REZUMAT

În ultimii ani, utilizarea unor metode complementare şi alternative în pediatrie a crescut considerabil, în special pentru afecţiunile cronice precum artrita juvenilă idiopatică, în care durerea poate fi o problemă semnificativă. Interesul crescut în abordările medicinei complementare şi alternative pentru simptomele durerii la copii şi adolescenţi, precum şi la populaţia adultă, a concentrat atenţia asupra problemelor de siguranţă şi eficacitate ale acestor metode. Urmărirea unor intervenţii sigure, eficiente şi rentabile pentru durerea cronică la copiii care suferă de artrită juvenilă, folosite în locul sau împreună cu abordările medicale convenţionale, este un obiectiv valoros, care ar trebui să fie abordat cu cea mai mare rigoare ştiinţifică. Trebuie să gândim creativ şi diferit în scopul de a educa cadrele medicale, precum şi publicul larg, pentru a le schimba atitudinea.

Cuvinte cheie: cronic, durere, artrită, copil

Full text | PDF

Juvenile idiopathic arthritis – risk factors and clinical forms

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LX, Nr. 4, An 2011
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

Juvenile idiopathic arthritis – risk factors and clinical forms

, , , , and

ABSTRACT

The aim of this article is to determine the JIA’s risk factors and the prevalence of clinical forms, poiting out the difficulties of situating them at onset as well as in evolution taking into consideration a significant number of patients (169 cases). The outlined clinical forms (in order of frequency) were: oligoarthritis (44,17%), RFnegative polyarthritis (33.13%), enthesitis (11.24%), systemic arthritis (5.91%), RF-positive polyarthritis (2, 95%) and psoriatic arthritis (2.36%), with the percentage values close to those of other studies, except the RF-negative polyarthritis subtype in which the frequency is higher. Individualized analysis of cases revealed real time from onset of disease to diagnosis and risk factors for JIA (in order of frequency): traumatic (9,46%), positive family history (5,32%) and infections (2,35%). Also, it emphasized the possibility of transforming a clinical form to another even under adequate treatment.

Key words: juvenile idiopathic arthritis, risk factors, clinical forms

Full text | PDF

ARTRITA JUVENILA IDIOPATICA – FACTORI DE RISC SI FORME CLINICE. STUDIU CAZUISTIC

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LX, Nr. 4, An 2011
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

ARTRITA JUVENILA IDIOPATICA – FACTORI DE RISC SI FORME CLINICE. STUDIU CAZUISTIC

, , , , and

REZUMAT

Obiectivul este de a stabili factorii de risc şi prevalenţa formelor clinice de AJI cu evidenţierea dificultăţilor de încadrare la debut şi în evoluţie luând în studiu un lot semnificativ de bolnavi (169 cazuri). Formele clinice conturate (în ordinea frecvenţei) au fost: oligoarticulară (44,17%), poliarticulară cu FR negativ (33,13), entezită (11,24%), sistemică (5,91%), poliarticulară cu FR pozitiv (2,95%) şi psoriazică (2,36%). Analiza individualizată a cazuisticii a scos în evidenţă durata de la debutul real al bolii până la diagnostic, cât şi factorii de risc pentru AJI (în ordinea frecvenţei): traumatici (9,46%), antecedente familiale pozitive (5,32%) şi infecţioşi (2,36%). De asemenea, a fost evidenţiată posibilitatea transformării unei forme clinice în alta chiar sub tratament adecvat.

Cuvinte cheie: artrită juvenilă idiopatică, factori de risc, forme clinice

Full text | PDF

Therapy with biological agents in juvenile-onset ankylosing spondylarthritis

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXI, Nr. 3, An 2012
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

Therapy with biological agents in juvenile-onset ankylosing spondylarthritis

, , and

REZUMAT

Ankylosing spondylarthritis is an immune-mediated inflammatory disease, which includes axial and peripheral arthritis, inflammation of the site where tendons and joint capsules attaches to the bone and degeneration of the sacroiliac joint and the spinal cord joints, leading to progressive spinal fusions. Introduction of new immunomodulatory molecules into therapy aiming at interleukins, such as the tumor necrosis factor alpha, was considered a major breakthrough in the treatment of severe ankylosing spondylarthritis. This case illustrates the particular evolution of the clinical manifestations in correlation with joint trauma, gastrointestinal infection and the devastating consequences of active HLA-B27 positive ankylosing spondylarthritis with juvenile onset.

Key words: spondylarthritis, enthesitis, ankylosing, juvenile, biological agents

Full text | PDF

TERAPIA CU AGENTI BIOLOGICI IN SPONDILARTRITA ANKILOZANTA CU DEBUT JUVENIL

SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LXI, Nr. 3, An 2012
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

TERAPIA CU AGENTI BIOLOGICI IN SPONDILARTRITA ANKILOZANTA CU DEBUT JUVENIL

, , and

REZUMAT

Spondilartrita anchilozantă este o boalǎ inflamatorie mediată imun, care include artrita axială şi periferică, inflamaţia locului unde tendoanele şi capsulele articulare se inseră pe os, precum şi degenerarea articulaţiilor sacro-iliace şi ale coloanei vertebrale, care conduce la fuziuni progresive ale vertebrelor. Introducerea în terapie a moleculelor imunomodulatoare, cu ţintă pe interleukine, cum ar fi pe factorul de necroză tumorală alfa, a fost considerată ca un progres major în tratamentul formelor severe de spondiliartrite ankilozante. Acest caz ilustrează evoluţia particulară a manifestărilor clinice în corelaţie cu traumatismul articular, infecţia digestivă şi consecinţele devastatoare ale spondilitei ankilozante active HLA-B27 pozitivă cu debut juvenil.

Cuvinte cheie: spondilartrită, entezită, ankilozantă, juvenilă, agenţi biologici

Full text | PDF